The DOH-NCPAM is embarking on a program that will provide health care access to patients with rare disease through the Rare Disease Medicines Access Program. Filipino patients born with rare disease are "orphaned" by society. They suffer social abandonment because of lack of existing network of support to aid them. Medical help is exclusive under the conditions of the country's health priority. The nature of their illness is hardly know due to lack of information and only a few medical professionals in the country are aware of these disorders and known how to diagnose and address these conditions.
- Improving Access to Medicines by Integrating Pharmaceutical Care Services in Public Health through F1+ Botika ng Bayan (BNB)
- Call for Nominations for the Health Technology Assessment Committee (HTAC)
- Administrative Order No. 2019-0002 "Implementing Guidelines on the Philippine Antimicrobial Stewardship (AMS) Program for Hospitals"
- Submission of 2019 Applications for Inclusion in the Philippine National Formulary (PNF)
- National Antibiotic Guidelines 2019
- DOH, DA, AND UN Agencies Call For United Fight Against Antimicrobial Resistance